Mass Spectrometry Based Metabolomics towards Pancreatic Cancer diagnostic test development.Wednesday, 26 September 2012 at 14:45 Add to Calendar ▼2012-09-26 14:45:002012-09-26 15:45:00Europe/LondonMass Spectrometry Based Metabolomics towards Pancreatic Cancer diagnostic test development.Molecular Diagnostics World Congress in San Diego, USASan Diego, USASELECTBIOenquiries@selectbiosciences.com Prospective cohort study has been performed utilizing Mass Spectrometry Based Metabolomics platform. Potential metabolic biomarkers were suggested. Pathway Analysis reveals impacted metabolic pathways and suggests new companion diagnostic targets. |